From www.ReplaceNAFTA.org: New NAFTA 'still includes problematic terms.'

Just now, The House of Representatives passed a revised version of the North American Free Trade Agreement (NAFTA). The deal will be considered by the Senate in early 2020.

For over a year we have been working to force essential improvements to Trump’s worse-than-the-original NAFTA 2.0 deal. That non-starter was rigged for Big Pharma to lock in high medicine prices and would have done nothing to stop NAFTA outsourcing of jobs or pollution.

Your efforts got Trump’s Big Pharma giveaways out and improved labor and environmental terms and enforcement in. As a result, the final revised deal is better than the original NAFTA and could stop some of NAFTA’s ongoing damage, although it still includes problematic terms.

If not for the relentless efforts of activists, civil society and our congressional champions like Rep. Rosa DeLauro, the Trump administration would have happily enacted a NAFTA 2.0 that would have handcuffed Congress’ ability to lower prescription drug prices.

Even with the improvements we won, this deal is by no means a model for trade agreements moving forward, and our coalition remains committed to working together for better policies in the future.

Below is a statement from Public Citizen's Global Trade Watch explaining in detail what this new agreement means.

We want to thank you for all of your work in this fight. It really does make a difference. We see that every day up close here two blocks from the Capitol.
We look forward to continuing to fight alongside you in the future for trade policies that put people and the planet above corporate profits.

In solidarity,
Ryan Harvey & the Replace NAFTA team